✦ LIBER ✦
Enduring Response to Everolimus as Third-Line Therapy in a Patient With Advanced Renal Cell Carcinoma, Including Small-Bowel Metastases: Loss of FHIT but Normal VHL Gene Status
✍ Scribed by Reuben J. Broom; Imogen Caldwell; Fritha Hanning; Peter Fong; Sanjeev Deva; Paul Oei
- Book ID
- 118430449
- Publisher
- CIG Media Group, LP.
- Year
- 2012
- Tongue
- English
- Weight
- 1002 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1558-7673
No coin nor oath required. For personal study only.